Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study.

IF 8.5 1区 医学 Q1 INFECTIOUS DISEASES
Hoai-An Nguyen, Anton Y Peleg, Jiangning Song, Jessica A Wisniewski, Luke V Blakeway, Gnei Z Badoordeen, Ravali Theegala, Nhu Quynh Doan, Matthew H Parker, David L Dowe, Nenad Macesic
{"title":"Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study.","authors":"Hoai-An Nguyen, Anton Y Peleg, Jiangning Song, Jessica A Wisniewski, Luke V Blakeway, Gnei Z Badoordeen, Ravali Theegala, Nhu Quynh Doan, Matthew H Parker, David L Dowe, Nenad Macesic","doi":"10.1016/j.cmi.2025.09.015","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to conduct a comprehensive genomic analysis of ceftolozane/tazobactam (C/T) resistance mechanisms in Pseudomonas aeruginosa by combining novel institutional data with publicly available sequencing data.</p><p><strong>Methods: </strong>We analysed 1,682 P. aeruginosa isolates, comprising 339 isolates from Alfred Hospital (Melbourne, Australia) and 1,343 isolates from six public datasets. All isolates underwent whole-genome sequencing and C/T broth microdilution (BMD) susceptibility testing. We assessed previously reported intrinsic and acquired resistance mechanisms. We then conducted a genome-wide association study (GWAS) and machine learning analysis to identify novel genes associated with resistance. We then evaluated the impact of mutations in these genes on MIC values and ceftolozane binding affinity.</p><p><strong>Results: </strong>Among 1,682 P. aeruginosa isolates representing 527 distinct sequence types, 343/1,682 (20.4%) were C/T-resistant. Carbapenemase genes were detected in 206/1,682 (12.2%) isolates. Mutations in previously reported resistance-associated genes (ftsI, mpl, ampD, ampC, ampR, oprD) were more frequent in resistant isolates but were also found in almost all susceptible isolates. Successive mutations conferred additive increases in MIC. Combined GWAS and machine learning analyses a priori identified five key genes significantly associated with resistance: ftsI, ampR, ampC, PA3329, and PA4311. Molecular docking simulation revealed that the R504C mutation in penicillin-binding protein 3 (PBP3), which is encoded by ftsI, reduced binding contacts and hydrogen bonds with ceftolozane, significantly decreasing binding affinity (P=0.016).</p><p><strong>Conclusions: </strong>Our analysis of 1,682 P. aeruginosa genomes demonstrated complex pathways to C/T resistance and showed that ftsI may play an underappreciated role. We discovered two previously unidentified genes associated with C/T resistance, whose function remains to be determined.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":8.5000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2025.09.015","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: We aimed to conduct a comprehensive genomic analysis of ceftolozane/tazobactam (C/T) resistance mechanisms in Pseudomonas aeruginosa by combining novel institutional data with publicly available sequencing data.

Methods: We analysed 1,682 P. aeruginosa isolates, comprising 339 isolates from Alfred Hospital (Melbourne, Australia) and 1,343 isolates from six public datasets. All isolates underwent whole-genome sequencing and C/T broth microdilution (BMD) susceptibility testing. We assessed previously reported intrinsic and acquired resistance mechanisms. We then conducted a genome-wide association study (GWAS) and machine learning analysis to identify novel genes associated with resistance. We then evaluated the impact of mutations in these genes on MIC values and ceftolozane binding affinity.

Results: Among 1,682 P. aeruginosa isolates representing 527 distinct sequence types, 343/1,682 (20.4%) were C/T-resistant. Carbapenemase genes were detected in 206/1,682 (12.2%) isolates. Mutations in previously reported resistance-associated genes (ftsI, mpl, ampD, ampC, ampR, oprD) were more frequent in resistant isolates but were also found in almost all susceptible isolates. Successive mutations conferred additive increases in MIC. Combined GWAS and machine learning analyses a priori identified five key genes significantly associated with resistance: ftsI, ampR, ampC, PA3329, and PA4311. Molecular docking simulation revealed that the R504C mutation in penicillin-binding protein 3 (PBP3), which is encoded by ftsI, reduced binding contacts and hydrogen bonds with ceftolozane, significantly decreasing binding affinity (P=0.016).

Conclusions: Our analysis of 1,682 P. aeruginosa genomes demonstrated complex pathways to C/T resistance and showed that ftsI may play an underappreciated role. We discovered two previously unidentified genes associated with C/T resistance, whose function remains to be determined.

临床铜绿假单胞菌对头孢唑烷-他唑巴坦耐药的复杂途径:基因组流行病学研究。
目的:我们旨在通过结合新的机构数据和公开的测序数据,对铜绿假单胞菌(Pseudomonas aeruginosa)的头孢唑烷/他唑巴坦(C/T)耐药机制进行全面的基因组分析。方法:对1682株铜绿假单胞菌进行分析,其中339株来自澳大利亚墨尔本阿尔弗雷德医院,1343株来自6个公共数据集。所有分离株均进行了全基因组测序和C/T肉汤微稀释(BMD)药敏试验。我们评估了先前报道的内在和获得性耐药机制。然后,我们进行了全基因组关联研究(GWAS)和机器学习分析,以确定与抗性相关的新基因。然后,我们评估了这些基因突变对MIC值和头孢氧杂烷结合亲和力的影响。结果:1682株铜绿假单胞菌(P. aeruginosa)有527个不同序列型,其中343/ 1682株(20.4%)具有C/ t耐药。碳青霉烯酶基因在206/ 1682株(12.2%)中检出。先前报道的耐药相关基因(ftsI、mpl、ampD、ampC、ampR、oprD)的突变在耐药菌株中更为常见,但在几乎所有易感菌株中也发现了突变。连续突变导致MIC增加。结合GWAS和机器学习分析,先验地确定了与耐药性显著相关的五个关键基因:ftsI、ampR、ampC、PA3329和PA4311。分子对接模拟结果显示,ftsI编码的青霉素结合蛋白3 (PBP3) R504C突变减少了与头孢唑烷的结合接触和氢键,显著降低了结合亲和力(P=0.016)。结论:我们对1682个铜绿假单胞菌基因组的分析显示了C/T耐药的复杂途径,并表明ftsI可能发挥了未被充分认识的作用。我们发现了两个先前未确定的与C/T耐药性相关的基因,其功能仍有待确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信